Pharmaceuticals & Medical Research Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 2,145 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Industry Group Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals Mega (1.0tn) 0 No activity — 0–15%
Pharmaceuticals Mega (653.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals Mega (500.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mega (372.3bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Mega (313.6bn) 0 No activity — —
CH Novartis AG (NOVN)
Pharmaceuticals Mega (275.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mega (249.4bn) 1–5 $10M–$100M 0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals Mega (221.8bn) -1–5 -$1M–$10M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals Mega (201.4bn) 0 No activity — 0–15%
Pharmaceuticals Large (190.4bn) 0 No activity — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals Large (166.5bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals Large (130.4bn) 0 No activity — 0–15%
Pharmaceuticals Large (125.5bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals Large (97.8bn) 0 No activity — 0–15%
GB GSK plc (GSK)
Pharmaceuticals Large (92.8bn) 11–20 -$100K–$1M -0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals Large (90.6bn) 0 No activity — 0–15%
US Moderna Inc (MRNA)
Biotechnology & Medical Research Large (90.3bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (77.5bn) 0 No activity — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals Large (77.0bn) 0 No activity — —
US Allergan plc (AGN)
Pharmaceuticals Large (63.7bn) 0 No activity — 0–15%
NL argenx SE (ARGX)
Biotechnology & Medical Research Large (59.5bn) -6–10 -$10M–$100M -0–15% 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals Large (55.1bn) 0 No activity — —
Biotechnology & Medical Research Large (53.1bn) 0 No activity — 0–15%
Pharmaceuticals Large (51.4bn) -6–10 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (50.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (44.1bn) -6–10 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (43.8bn) -1–5 -$1M–$10M -0–15% 0–15%
BE Ucb SA (UCB)
Pharmaceuticals Large (43.5bn) 1–5 $100K–$1M 0–15% 15–50%
US Seagen Inc (SGEN)
Biotechnology & Medical Research Large (43.2bn) 0 No activity — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals Large (39.7bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals Large (39.5bn) 0 No activity — 0–15%
Pharmaceuticals Large (33.8bn) 0 No activity — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals Large (33.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (32.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (32.0bn) 0 No activity — 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals Large (28.9bn) 0 No activity — 0–15%
Pharmaceuticals Large (27.6bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals Large (26.7bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals Large (26.6bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (26.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (23.9bn) -6–10 -$10M–$100M -0–15% 0–15%
DE Biontech SE (BNTX)
Biotechnology & Medical Research Large (23.1bn) -1–5 -$10M–$100M -0–15% 50%+
Pharmaceuticals Large (22.9bn) -1–5 -$100K–$1M -0–15% 0–15%
US Incyte Corp (INCY)
Pharmaceuticals Large (22.6bn) -1–5 -$10M–$100M -0–15% 0–15%
DK Genmab A/S (GMAB)
Biotechnology & Medical Research Large (22.3bn) 0 No activity — 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals Large (20.9bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (20.3bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (20.0bn) 0 No activity — 0–15%
Pharmaceuticals Large (19.4bn) 0 No activity — 50%+
Biotechnology & Medical Research Large (16.8bn) -6–10 -$100M+ -0–15% 15–50%
Pharmaceuticals Large (16.6bn) -1–5 -$10M–$100M -0–15% 0–15%
IN Cipla Ltd (CIPLA)
Pharmaceuticals Large (15.9bn) 0 No activity — 15–50%
US Exelixis Inc (EXEL)
Biotechnology & Medical Research Large (15.1bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (14.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (14.5bn) 0 No activity — 0–15%
Pharmaceuticals Large (14.2bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (14.0bn) 0 No activity — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals Large (14.0bn) 1–5 $100K–$1M 0–15% 50%+
Biotechnology & Medical Research Large (13.9bn) -6–10 -$10M–$100M -0–15% 15–50%
Biotechnology & Medical Research Large (13.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (13.5bn) 0 No activity — 0–15%
Pharmaceuticals Large (13.3bn) 0 No activity — 0–15%
Pharmaceuticals Large (13.2bn) 0 No activity — 50%+
FI Orion Oyj (ORNBV)
Pharmaceuticals Large (13.0bn) 0 No activity — 0–15%
Pharmaceuticals Large (12.9bn) 0 No activity — 50%+
IE ICON PLC (ICLR)
Biotechnology & Medical Research Large (12.9bn) -6–10 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (12.6bn) 0 No activity — 0–15%
Pharmaceuticals Large (12.5bn) 0 No activity — 50%+
Pharmaceuticals Large (12.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Large (12.4bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals Large (12.3bn) -1–5 -$1M–$10M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Biotechnology & Medical Research Large (12.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (12.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (11.6bn) -1–5 -$1M–$10M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals Large (11.5bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (11.4bn) 0 No activity — 0–15%
Pharmaceuticals Large (11.3bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals Large (11.2bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (11.0bn) 0 No activity — 15–50%
Biotechnology & Medical Research Large (10.9bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (10.9bn) 0 No activity — 50%+
Pharmaceuticals Large (10.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (10.3bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (10.2bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (10.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (10.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (9.9bn) 0 No activity — 50%+
Biotechnology & Medical Research Mid (9.8bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (9.6bn) 0 No activity — 15–50%
Biotechnology & Medical Research Mid (9.1bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (9.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (9.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Mid (8.8bn) -1–5 -$10M–$100M -0–15% 0–15%
US ImmunoGen Inc (IMGN)
Biotechnology & Medical Research Mid (8.7bn) 0 No activity — 0–15%
US Mylan NV (MYL)
Pharmaceuticals Mid (8.6bn) 0 No activity — 0–15%
US Vaxcyte Inc (PCVX)
Biotechnology & Medical Research Mid (8.4bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.4bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.4bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Abivax SA (ABVX)
Biotechnology & Medical Research Mid (8.3bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.2bn) -1–5 -$1M–$10M -0–15% 0–15%